---
schema_version: "secwatch.filing_event.v1"
accession: "0001127537-24-000039"
form_type: "8-K"
ticker: "LUNG"
cik: "0001127537"
company_name: "Pulmonx Corp"
filed_at: "2024-04-02T23:59:59+00:00"
generated_at: "2026-06-04T03:18:33.591878+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Pulmonx appoints Mehul Joshi as CFO effective April 3, 2024

## Summary
- Mehul Joshi named CFO; previously CFO of PhenomeX and senior finance roles at ResMed and Gilead.
- Annual base salary $450K; target bonus 50% of base; sign-on bonus $200K with clawback provisions.
- Initial equity grants: non-statutory stock option valued at $1.375M and RSU valued at $1.35M, both vesting over 4 years.
- John McKune, interim CFO since Oct 2023, returns to VP Finance and Corporate Controller.
- Severance and change-in-control benefits: 12 months salary plus bonus acceleration upon qualifying termination.

## SEC filing metadata
- accession: 0001127537-24-000039
- form_type: 8-K
- ticker: LUNG
- cik: 0001127537
- company_name: Pulmonx Corp
- filed_at: 2024-04-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1127537/000112753724000039/0001127537-24-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1127537/000112753724000039/lung-20240402.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001127537-24-000039
- JSON: https://secwatch.observer/filing/0001127537-24-000039.json
- Plain text: https://secwatch.observer/filing/0001127537-24-000039.txt

## Key facts
- Executive change
  Mehul Joshi was appointed as Chief Financial Officer and Principal Financial and Accounting Officer at Pulmonx Corp.
  - Action: appointed
  - Role: Chief Financial Officer and Principal Financial and Accounting Officer
  source text: On March 19, 2024, the board of directors of Pulmonx Corporation (the “Company”) appointed Mehul Joshi as the Company’s Chief Financial Officer and Principal Financial and Accounting Officer, effective upon commencement of his employment with the Company on April 3, 2024 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1127537/000112753724000039/0001127537-24-000039-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.